Skip to main content
. 2023 Apr 21;103:4805. doi: 10.2340/actadv.v103.4805

Table I.

Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) of 2 cases

Before After 2 months At withdrawal
Case1 mLoSSI 6 3 1
LosDi 7 5 2
Case2 mLoSSI 7 3 1
LosDi 7 4 2

The LoSCAT scale was used to assess disease-related activity and damage, performed independently by 2 clinicians. All of the scores were considerably reduced after medication.

mLoSSI: modified LS Skin Severity Index, which measures disease activity; LosDi: Localized scleroderma Damage Index, which measures damage.